Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza Phase III SOLO-2 trial shows significant progression-free survival benefit
-
FDA accepts for review New Drug Application for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalaemia
-
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
-
AstraZeneca enters agreement with Aralez for beta-blocker medicine Toprol-XL in the US
-
AstraZeneca reports top-line results from the Brilinta EUCLID trial in patients with peripheral artery disease
-
MedImmune out-licenses potential medicine for inflammatory diseases to Allergan
-
AstraZeneca presents new data on Faslodex in breast cancer and provides immuno-oncology update at ESMO 2016 congress
-
AstraZeneca provides update on cediranib EU marketing authorisation application
-
Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 diabetes
-
AstraZeneca announces two new phase IIIb trials for Forxiga in chronic kidney disease and chronic heart failure
Latest articles and press releases
All of our latest press releases and articles are available to explore
